Interferon-alpha for viral hepatitis

被引：21

作者：

Jonas, MM ^{[1
]}

机构：

[1] CHILDRENS HOSP, COMBINED PROGRAM GASTROENTEROL, BOSTON, MA USA

来源：

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 1996年 / 23卷 / 02期

关键词：

D O I：

10.1097/00005176-199608000-00001

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：93 / 106

页数：14

共 150 条

[21]

*CTR DIS CONTR, 1992, 54 CTR DIS CONTR, P11

[22] JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].

DARNELL, JE ;

KERR, IM ;

STARK, GR .

SCIENCE, 1994, 264 (5164) :1415-1421

[23] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL [J].

DAVIS, GL ;

BALART, LA ;

SCHIFF, ER ;

LINDSAY, K ;

BODENHEIMER, HC ;

PERRILLO, RP ;

CAREY, W ;

JACOBSON, IM ;

PAYNE, J ;

DIENSTAG, JL ;

VANTHIEL, DH ;

TAMBURRO, C ;

LEFKOWITCH, J ;

ALBRECHT, J ;

MESCHIEVITZ, C ;

ORTEGO, TJ ;

GIBAS, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1501-1506

[24]

DeMaeyer E, 1987, INTERFERON SYSTEM CU, P327

[25]

DESMET VJ, 1991, HEPATO-GASTROENTEROL, V38, P14

[26] RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DIBISCEGLIE, AM ;

MARTIN, P ;

KASSIANIDES, C ;

LISKERMELMAN, M ;

MURRAY, L ;

WAGGONER, J ;

GOODMAN, Z ;

BANKS, SM ;

HOOFNAGLE, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1506-1510

[27] CHANGES IN HEPATITIS-C VIRUS-ANTIGEN IN LIVER WITH ANTIVIRAL THERAPY [J].

DIBISCEGLIE, AM ;

HOOFNAGLE, JH ;

KRAWCZYNSKI, K .

GASTROENTEROLOGY, 1993, 105 (03) :858-862

[28] INTERFERON-ALFA-2B FOR DECOMPENSATED LIVER-DISEASE CAUSED BY EITHER CHRONIC HEPATITIS-B OR HEPATITIS-C - PRELIMINARY-RESULTS OF A PILOT-STUDY [J].

DIMOPOULOU, M ;

FAFOUTIS, K ;

BASILIOU, K ;

KETIKOGLOU, J ;

KARVOUNTZIS, G .

GUT, 1993, 34 (02) :S104-S105

[29] RANDOMIZED CONTROLLED TRIAL OF RECOMBINANT INTERFERON-ALPHA-2A FOR CHRONIC HEPATITIS-C - COMPARISON OF ALANINE AMINOTRANSFERASE NORMALIZATION VERSUS LOSS OF HCV RNA AND ANTI-HCV IGM [J].

DOUGLAS, DD ;

RAKELA, J ;

LIN, HJ ;

HOLLINGER, FB ;

TASWELL, HF ;

CZAJA, AJ ;

GROSS, JB ;

ANDERSON, ML ;

PARENT, K ;

FLEMING, CR ;

CANGEMI, JR ;

OBRIEN, PC ;

POWIS, PE .

DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (04) :601-607

[30] DEVELOPMENT OF TYPE-1 DIABETES-MELLITUS DURING INTERFERON-ALFA THERAPY FOR CHRONIC HCV HEPATITIS [J].

FABRIS, P ;

BETTERLE, C ;

FLOREANI, A ;

GREGGIO, NA ;

DELAZZARI, F ;

NACCARATO, R ;

CHIARAMONTE, M .

LANCET, 1992, 340 (8818) :548-548

← 1 2 3 4 5 6 7 8 9 10 →